Evinova and Lothar Medical Partner to Modernize Respiratory Trials
Baar, Switzerland — September 5, 2026 Evinova announced a strategic partnership with Lothar Medical to modernize the execution of...
bronchiectasis
Advertisement
Insmed Presents New ARIKAYCE Data From Phase 3b ENCORE
Bridgewater, New Jersey, USA, September 3, 2026 Insmed Incorporated announced that five abstracts from its respiratory portfolio have been...
Infex Therapeutics Advances RESP-X Phase IIa Data at ERS 2026
Alderley Park, Cheshire, U.K., August 19, 2026 Infex Therapeutics will present new Phase IIa data for RESP-X (INFEX702) in...
Infex Therapeutics Reports Positive Phase IIa RESP-X Data in Bronchiectasis
Alderley Park, Cheshire, U.K., May 21, 2026 Infex Therapeutics announced positive Phase IIa clinical trial results for RESP-X (INFEX702)...
Insmed Unveils Phase 3 ARIKAYCE Data at ATS 2026
BRIDGEWATER, NEW JERSEY, May 04, 2026 Insmed Incorporated has announced the presentation of multiple clinical and real-world data sets...
Advertisement
